Sio Capital Management LLC's Q1 2023 13F: 17 new positions, 14 exits
Form 13F-HR for the quarter ended Mar 31, 2023 · filed May 12, 2023 · 44 reported positions · accession 0001214659-23-006952
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| New | CENTENE CORP DEL (CNC) | — | 13.5% | +13.5 pts | +433K sh | new |
| Exited | MEDICUS SCIENCES ACQUISITION (MSAC) | 12.5% | — | −12.5 pts | −2.32M sh | −100% |
| New | GE HEALTHCARE TECHNOLOGIES INC (GEHC) | — | 8.0% | +8.0 pts | +197K sh | new |
| Increased | CIGNA GROUP (CI) | 9.3% | 11.0% | +1.7 pts | +34,564 sh | +66% |
| Exited | STAAR SURGICAL CO (STAA) | 4.1% | — | −4.1 pts | −157K sh | −100% |
| Exited | ICON PLC (ICLR) | 3.5% | — | −3.5 pts | −33,983 sh | −100% |
| Increased | AMERISOURCEBERGEN CORP (COR) | 7.5% | 10.1% | +2.7 pts | +43,765 sh | +52% |
| Reduced | HESKA CORP (HSKA) | 2.8% | 0.8% | −2.0 pts | −66,859 sh | −79% |
| Increased | BICYCLE THERAPEUTICS PLC (BCYC) | 10.8% | 10.2% | −0.6 pts | +284K sh | +42% |
| Exited | PROTAGONIST THERAPEUTICS INC (PTGX) | 2.5% | — | −2.5 pts | −435K sh | −100% |
| Increased | UNITED THERAPEUTICS CORP (UTHR) | 8.1% | 8.3% | +0.2 pts | +20,044 sh | +36% |
| New | ADC THERAPEUTICS SA (ADCT) | — | 2.1% | +2.1 pts | +2.16M sh | new |
| New | VIKING THERAPEUTICS INC (VKTX) | — | 2.1% | +2.1 pts | +250K sh | new |
| New | AXONICS INC (AXNX) | — | 1.9% | +1.9 pts | +70,841 sh | new |
| New | GLOBUS MEDICAL INC (GMED) | — | 1.9% | +1.9 pts | +67,500 sh | new |
| New | RELAY THERAPEUTICS INC (RLAY) | — | 1.9% | +1.9 pts | +230K sh | new |
| Exited | NOVAVAX INC (NVAX) | 1.9% | — | −1.9 pts | −340K sh | −100% |
| Exited | CYMABAY THERAPEUTICS INC (CBAY) | 1.9% | — | −1.9 pts | −556K sh | −100% |
| Reduced | MEDTRONIC PLC (MDT) | 5.3% | 3.3% | −2.0 pts | −43,988 sh | −34% |
| Reduced | ORGANON & CO (OGN) | 8.8% | 5.5% | −3.3 pts | −116K sh | −20% |
| New | REVOLUTION MEDICINES INC (RVMD) | — | 1.3% | +1.3 pts | +126K sh | new |
| Exited | HEALTH SCIENCES ACQUISITIONS CORP 2 (HSAQ) | 1.3% | — | −1.3 pts | −250K sh | −100% |
| New | REPARE THERAPEUTICS INC (RPTX) | — | 1.1% | +1.1 pts | +229K sh | new |
| Reduced | INOGEN INC (INGN) | 3.0% | 0.7% | −2.3 pts | −165K sh | −58% |
| Exited | X4 PHARMACEUTICALS INC (XFOR) | 1.0% | — | −1.0 pts | −1.83M sh | −100% |
| New | CENTESSA PHARMACEUTICALS PLC (CNTA) | — | 0.7% | +0.7 pts | +348K sh | new |
| Reduced | MERUS NV (MRUS) | 0.7% | 0.1% | −0.6 pts | −72,389 sh | −82% |
| Increased | NYXOAH SA (NYXH) | 0.0% | 0.7% | +0.7 pts | +173K sh | +1072% |
| Exited | TYRA BIOSCIENCES INC (TYRA) | 0.6% | — | −0.6 pts | −152K sh | −100% |
| New | APREA THERAPEUTICS INC (APRE) | — | 0.6% | +0.6 pts | +280K sh | new |
| New | CORBUS PHARMACEUTICALS HOLDINGS (CRBP) | — | 0.5% | +0.5 pts | +150K sh | new |
| Increased | ELEVATION ONCOLOGY INC (ELEV) | 0.2% | 0.8% | +0.6 pts | +517K sh | +144% |
| Exited | RELMADA THERAPEUTICS INC (RLMD) | 0.4% | — | −0.4 pts | −236K sh | −100% |
| Increased | CTI BIOPHARMA CORP (CTIC) | 1.1% | 1.1% | 0.0 pts | +196K sh | +59% |
| Increased | AVANTOR INC (AVTR) | 2.8% | 3.0% | +0.1 pts | +33,136 sh | +13% |
| New | NEOVASC INC (NVCN) | — | 0.3% | +0.3 pts | +22,537 sh | new |
| Exited | CONNECT BIOPHARMA HOLDINGS LTD (CNTB) | 0.3% | — | −0.3 pts | −598K sh | −100% |
| Exited | SIENTRA INC (SIEN) | 0.3% | — | −0.3 pts | −2.55M sh | −100% |
| Reduced | PHARVARIS NV (PHVS) | 1.7% | 0.9% | −0.8 pts | −56,615 sh | −20% |
| New | SIENTRA INC (SIENQ) | — | 0.2% | +0.2 pts | +255K sh | new |
| Increased | MERRIMACK PHARMACEUTICALS INC (MACK) | 1.5% | 1.7% | +0.1 pts | +22,843 sh | +9% |
| Increased | SAVARA INC (SVRA) | 0.7% | 0.9% | +0.2 pts | +82,009 sh | +9% |
| Reduced | VANDA PHARMACEUTICALS INC (VNDA) | 0.5% | 0.4% | −0.1 pts | −12,528 sh | −9% |
| New | ROCKET PHARMACEUTICALS INC (RCKTW) | — | 0.0% | 0.0 pts | +400K sh | new |
| Reduced | FUSION PHARMACEUTICALS INC (FUSN) | 0.4% | 0.5% | 0.0 pts | −14,412 sh | −6% |
| Reduced | CAREMAX INC (CMAX) | 0.1% | 0.0% | 0.0 pts | −12,808 sh | −29% |
| New | HUMACYTE INC (HUMAW) | — | 0.0% | 0.0 pts | +49,998 sh | new |
| Reduced | MOLECULIN BIOTECH INC (MBRX) | 0.6% | 0.5% | −0.1 pts | −25,897 sh | −2% |
| Exited | HUMACYTE INC (HUMA) | 0.0% | — | 0.0 pts | −49,998 sh | −100% |
| Exited | NEOLEUKIN THERAPEUTICS INC (NLTX) | 0.0% | — | 0.0 pts | −38,312 sh | −100% |
The 50 largest of 51 changes, by size of the trade. Full holdings for this quarter.
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
† Security identifier (CUSIP) changed — read as one continuing position, not an exit and a new position:
- ASLAN PHARMACEUTICALS LTD (ASLN): 04522R101 → 04522R200, 1.27M → 254K shares (share count changed with the identifier; not shown as a trade)
Top 10 positions — 75.0% of the equity book
Changes in the top 10 this quarter: CNC entered · GEHC entered · AVTR entered · ADCT entered · MSAC left · STAA left · ICLR left · INGN left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | CENTENE CORP DEL (CNC) | 0.0% | 13.5% | Entered the top 10 |
| 2 | CIGNA GROUP (CI) | 9.3% | 11.0% | |
| 3 | BICYCLE THERAPEUTICS PLC (BCYC) | 10.8% | 10.2% | |
| 4 | AMERISOURCEBERGEN CORP (COR) | 7.5% | 10.1% | |
| 5 | UNITED THERAPEUTICS CORP (UTHR) | 8.1% | 8.3% | |
| 6 | GE HEALTHCARE TECHNOLOGIES INC (GEHC) | 0.0% | 8.0% | Entered the top 10 |
| 7 | ORGANON & CO (OGN) | 8.8% | 5.5% | |
| 8 | MEDTRONIC PLC (MDT) | 5.3% | 3.3% | |
| 9 | AVANTOR INC (AVTR) | 2.8% | 3.0% | Entered the top 10 |
| 10 | ADC THERAPEUTICS SA (ADCT) | 0.0% | 2.1% | Entered the top 10 |
| — | MEDICUS SCIENCES ACQUISITION (MSAC) | 12.5% | 0.0% | Left the top 10 |
| — | STAAR SURGICAL CO (STAA) | 4.1% | 0.0% | Left the top 10 |
| — | ICON PLC (ICLR) | 3.5% | 0.0% | Left the top 10 |
| — | INOGEN INC (INGN) | 3.0% | 0.7% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).
Option positions (puts and calls)
Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.
| Activity | Security | Type | Shares before | Shares now | Reported value |
|---|---|---|---|---|---|
| Exited | PROMETHEUS BIOSCIENCES INC (RXDX) | Put | 574K | 0 | $0 |
| Exited | QUEST DIAGNOSTICS INC (DGX) | Put | 92,000 | 0 | $0 |
| Exited | REATA PHARMACEUTICALS INC (RETA) | Put | 67,000 | 0 | $0 |
| Exited | IVERIC BIO INC (ISEE) | Put | 86,400 | 0 | $0 |
| Exited | RELMADA THERAPEUTICS INC (RLMD) | Put | 236K | 0 | $0 |